Abstract
Viruses have evolved diverse immune evasion strategies, including the targeting of host pattern recognition receptors. The role of viral non-coding RNAs in modulating pattern recognition receptor activity is unclear. Here we show that human cytomegalovirus (HCMV) produces long non-coding RNA4.9 that counteracts the nuclear cyclic GMP–AMP synthase (cGAS)-mediated immune response to facilitate viral infection in human foreskin fibroblasts. RNA4.9 interacts with host cGAS via its 75-nucleotide RNA region with predicted hairpin loops. Binding of RNA4.9 to cGAS inhibits cGAS enzymatic activity as well as downstream interferon response and facilitates productive viral replication. Sterically blocking the folding of the 75-nucleotide region with antisense oligonucleotides during HCMV infection restores cGAS activity and impairs viral replication. In addition, we found that the specific localization of RNA4.9, which concentrates near HCMV DNA, is correlated with its efficient binding to cGAS and subsequent immune suppression. Our findings identify viral non-coding RNAs as key regulators of cGAS and highlight their potential as therapeutic targets.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
Data availability
The raw sequencing data of mRNA-seq and CLIP-seq were deposited in the National Center for Biotechnology Information Gene Expression Omnibus (NCBI GEO) database: GSE268887 and GSE270524, respectively. The whole-genome sequencing data from progeny viruses of the WT and mutant viruses were deposited in the NCBI Sequence Read Archive (SRA) under the BioProject PRJNA1232851. Reads from mRNA sequencing were aligned to the GRCh38 primary assembly (GENCODE V32). Reads from CLIP-seq were aligned to the GRCh38 primary assembly (GENCODE V45) and human herpesvirus 5 strain Toledo genome (GenBank accession GU937742.2). Reads from the whole-genome sequencing were aligned to the human herpesvirus 5 strain Toledo genome (GenBank accession GU937742.2). Source data are provided with this paper.
Code availability
The codes used for analysis of mRNA-seq, CLIP-seq and viral genome sequencing are available via GitHub at https://github.com/dohlee/viral-lncRNA-cGAS, https://github.com/hyejun18/cgas-clip-hcmv and https://github.com/hyejun18/hcmv-wgs-rna49, respectively.
References
Chathuranga, K., Weerawardhana, A., Dodantenna, N. & Lee, J. S. Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing. Exp. Mol. Med. 53, 1647–1668 (2021).
Bowie, A. G. & Unterholzner, L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol. 8, 911–922 (2008).
Tagawa, T., Serquina, A., Kook, I. & Ziegelbauer, J. Viral non-coding RNAs: stealth strategies in the tug-of-war between humans and herpesviruses. Semin. Cell Dev. Biol. 111, 135–147 (2021).
Li, Z. et al. Viral long non-coding RNA regulates virus life-cycle and pathogenicity. Mol. Biol. Rep. 49, 6693–6700 (2022).
Tycowski, K. T. et al. Viral noncoding RNAs: more surprises. Genes Dev. 29, 567–584 (2015).
Horos, R. et al. The small non-coding vault RNA1-1 acts as a riboregulator of autophagy. Cell 176, 1054–1067 (2019).
Sommerauer, C. & Kutter, C. Noncoding RNAs and RNA-binding proteins: emerging governors of liver physiology and metabolic diseases. Am. J. Physiol. Cell Physiol. 323, C1003–C1017 (2022).
Zuhair, M. et al. Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis. Rev. Med Virol. 29, e2034 (2019).
Alford, C. A., Stagno, S., Pass, R. F. & Britt, W. J. Congenital and perinatal cytomegalovirus infections. Rev. Infect. Dis. 12, S745–S753 (1990).
Britt, W. Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr. Top. Microbiol. Immunol. 325, 417–470 (2008).
Gatherer, D. et al. High-resolution human cytomegalovirus transcriptome. Proc. Natl Acad. Sci. USA 108, 19755–19760 (2011).
Prichard, M. N. et al. Identification of persistent RNA–DNA hybrid structures within the origin of replication of human cytomegalovirus. J. Virol. 72, 6997–7004 (1998).
Masse, M. J. O., Karlin, S., Schachtel, G. A. & Mocarski, E. S. Human cytomegalovirus origin of DNA-replication (Orilyt) resides within a highly complex repetitive region. Proc. Natl Acad. Sci. USA 89, 5246–5250 (1992).
Borst, E. M. & Messerle, M. Analysis of human cytomegalovirus oriLyt sequence requirements in the context of the viral genome. J. Virol. 79, 3615–3626 (2005).
Tai-Schmiedel, J. et al. Human cytomegalovirus long noncoding RNA4.9 regulates viral DNA replication. PLoS Pathog. 16, e1008390 (2020).
Lee, S. et al. Functional and molecular dissection of HCMV long non-coding RNAs. Sci. Rep. 12, 19303 (2022).
Wu, J. et al. Cyclic GMP–AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339, 826–830 (2013).
Tanaka, Y. & Chen, Z. J. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci. Signal 5, ra20 (2012).
Liu, S. et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347, aaa2630 (2015).
Schoggins, J. W. et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505, 691–695 (2014).
Huang, L. S. et al. mtDNA activates cGAS signaling and suppresses the YAP-mediated endothelial cell proliferation program to promote inflammatory injury. Immunity 52, 475–486.e5 (2020).
Gulen, M. F. et al. cGAS–STING drives ageing-related inflammation and neurodegeneration. Nature 620, 374–380 (2023).
Gao, D. et al. Activation of cyclic GMP–AMP synthase by self-DNA causes autoimmune diseases. Proc. Natl Acad. Sci. USA 112, E5699–E5705 (2015).
Civril, F. et al. Structural mechanism of cytosolic DNA sensing by cGAS. Nature 498, 332–337 (2013).
Chen, S., Rong, M., Lv, Y., Zhu, D. & Xiang, Y. Regulation of cGAS activity by RNA-modulated phase separation. EMBO Rep. 24, e51800 (2023).
Xia, P. et al. A circular RNA protects dormant hematopoietic stem cells from DNA sensor cGAS-mediated exhaustion. Immunity 48, 688–701.e7 (2018).
Yoneyama, M. et al. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17, 1087–1095 (1998).
Li, T., Chen, J. & Cristea, I. M. Human cytomegalovirus tegument protein pUL83 inhibits IFI16-mediated DNA sensing for immune evasion. Cell Host Microbe 14, 591–599 (2013).
Paijo, J. et al. cGAS senses human cytomegalovirus and induces type I interferon responses in human monocyte-derived cells. PLoS Pathog. 12, e1005546 (2016).
Biolatti, M. et al. Human cytomegalovirus tegument protein pp65 (pUL83) dampens type I interferon production by inactivating the DNA sensor cGAS without affecting STING. J. Virol. 92, e01774-17 (2018).
Huang, Z. F. et al. Human cytomegalovirus protein UL31 inhibits DNA sensing of cGAS to mediate immune evasion. Cell Host Microbe 24, 69–80.e4 (2018).
Gariano, G. R. et al. The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication. PLoS Pathog. 8, e1002498 (2012).
Fu, Y. Z. et al. Human cytomegalovirus protein UL42 antagonizes cGAS/MITA-mediated innate antiviral response. PLoS Pathog. 15, e1007691 (2019).
Volkman, H. E., Cambier, S., Gray, E. E. & Stetson, D. B. Tight nuclear tethering of cGAS is essential for preventing autoreactivity. eLife 8, e47491 (2019).
Kujirai, T. et al. Structural basis for the inhibition of cGAS by nucleosomes. Science 370, 455–458 (2020).
Li, T. et al. Phosphorylation and chromatin tethering prevent cGAS activation during mitosis. Science 371, eabc5386 (2021).
Tarn, W. Y., Cheng, Y., Ko, S. H. & Huang, L. M. Antisense oligonucleotide-based therapy of viral infections. Pharmaceutics 13, 2015 (2021).
Ahn, J. H., Jang, W. J. & Hayward, G. S. The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10). J. Virol. 73, 10458–10471 (1999).
Chiou, C. J., Zong, J., Waheed, I. & Hayward, G. S. Identification and mapping of dimerization and DNA-binding domains in the C terminus of the IE2 regulatory protein of human cytomegalovirus. J. Virol. 67, 6201–6214 (1993).
Lang, D. & Stamminger, T. The 86-kilodalton IE-2 protein of human cytomegalovirus is a sequence-specific DNA-binding protein that interacts directly with the negative autoregulatory response element located near the cap site of the IE-1/2 enhancer-promoter. J. Virol. 67, 323–331 (1993).
Ball, C. B. et al. Human cytomegalovirus IE2 both activates and represses initiation and modulates elongation in a context-dependent manner. mBio 13, e0033722 (2022).
Scherer, M. et al. Dual signaling via interferon and DNA damage response elicits entrapment by giant PML nuclear bodies. eLife 11, e73006 (2022).
Markaki, Y. et al. Xist nucleates local protein gradients to propagate silencing across the X chromosome. Cell 184, 6174–6192.e32 (2021).
Reeves, M. B., Davies, A. A., McSharry, B. P., Wilkinson, G. W. & Sinclair, J. H. Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death. Science 316, 1345–1348 (2007).
Zhang, L., Xu, J., Li, M. & Chen, X. The role of long noncoding RNAs in liquid–liquid phase separation. Cell Signal 111, 110848 (2023).
Loda, A. & Heard, E. Xist RNA in action: past, present, and future. PLoS Genet. 15, e1008333 (2019).
Yamazaki, T. et al. Functional domains of NEAT1 architectural lncRNA induce paraspeckle assembly through phase separation. Mol. Cell 70, 1038–1053 (2018).
West, J. A. et al. The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites. Mol. Cell 55, 791–802 (2014).
Song, Z. X., Lin, J. M., Li, Z. G. & Huang, C. The nuclear functions of long noncoding RNAs come into focus. Noncoding RNA Res. 6, 70–79 (2021).
Rossetto, C. C. & Pari, G. KSHV PAN RNA associates with demethylases UTX and JMJD3 to activate lytic replication through a physical interaction with the virus genome. PLoS Pathog. 8, e1002680 (2012).
Catez, F. et al. HSV-1 genome subnuclear positioning and associations with host-cell PML-NBs and centromeres regulate LAT locus transcription during latency in neurons. PLoS Pathog. 8, e1002852 (2012).
Gentili, M. et al. The N-terminal domain of cGAS determines preferential association with centromeric DNA and innate immune activation in the nucleus. Cell Rep. 26, 2377–2393.e13 (2019).
Zhong, L. et al. Phosphorylation of cGAS by CDK1 impairs self-DNA sensing in mitosis. Cell Discov. 6, 26 (2020).
Pathare, G. R. et al. Structural mechanism of cGAS inhibition by the nucleosome. Nature 587, 668–672 (2020).
Banerjee, D. et al. A non-canonical, interferon-independent signaling activity of cGAMP triggers DNA damage response signaling. Nat. Commun. 12, 6207 (2021).
Lahaye, X. et al. NONO detects the nuclear HIV capsid to promote cGAS-mediated innate immune activation. Cell 175, 488–501 (2018).
Liu, H. et al. Nuclear cGAS suppresses DNA repair and promotes tumorigenesis. Nature 563, 131–136 (2018).
Wu, Y. et al. Nuclear soluble cGAS senses double-stranded DNA virus infection. Commun. Biol. 5, 433 (2022).
Mendelson, M., Monard, S., Sissons, P. & Sinclair, J. Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J. Gen. Virol. 77, 3099–3102 (1996).
Vonlaer, D. et al. Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrow. Blood 86, 4086–4090 (1995).
Cohen, J. I. Herpesvirus latency. J. Clin. Invest. 130, 3361–3369 (2020).
Rossetto, C. C., Tarrant-Elorza, M. & Pari, G. S. Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14+ monocytes and CD34+ cells. PLoS Pathog. 9, e1003366 (2013).
Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884–i890 (2018).
Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589–595 (2010).
Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008 (2021).
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).
Harrow, J. et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 22, 1760–1774 (2012).
Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).
Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90–W97 (2016).
Fang, Z., Liu, X. & Peltz, G. GSEApy: a comprehensive package for performing gene set enrichment analysis in Python. Bioinformatics 39, btac757 (2023).
Kim, S. et al. Temporal landscape of microRNA-mediated host–virus crosstalk during productive human cytomegalovirus infection. Cell Host Microbe 17, 838–851 (2015).
Smith, T., Heger, A. & Sudbery, I. UMI-tools: modeling sequencing errors in unique molecular identifiers to improve quantification accuracy. Genome Res. 27, 491–499 (2017).
Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).
Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).
Virtanen, P. et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat. Methods 17, 261–272 (2020).
Dunn, O. J. Multiple comparisons among means. J. Am. Stat. Assoc. 56, 52–64 (1961).
Acknowledgements
We thank all laboratory members for their productive discussions. We also thank T. Shenk for providing HCMV Toledo-BAC (AC146905.1). This work was supported by Institute for Basic Science IBS-R008-D1 (to K.A.), National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) RS-2020-NR049538 (to K.A.) and NRF-2020R1A2C3011298 to (to K.A.). This work was partially supported by funds from the SNU Institute for Virus Research.
Author information
Authors and Affiliations
Contributions
S.L. and K.A. contributed to the conceptualization and design of overall experiments. S.L. conducted virus infection and cell biological experiments. Sungchul Kim provided support for the construction of the CLIP library and SMI library. Hyejun Kim and V.N.K. contributed to bioinformatics analysis of CLIP-seq. D.L. and Sun Kim conducted mRNA sequencing analysis. J.P. contributed the microscopic image analyses. D.J., Hyewon Kim and K.P. performed biochemical experiments and cell line generation. J.H. provided support for the experiments using primary HUVEC cells. S.L., K.P., J.P. and K.A. wrote the paper.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Microbiology thanks Alfredo Castello, Ian Mohr, Søren Paludan and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 The 1.9–4.9-kb region of RNA4.9 plays a critical role in suppressing innate immune response.
(a) Graphical abstract describing each recombinant virus. HFFs infected with WT and 1.9–4.9krpsL HCMV (1 MOI, 6 hpi) were analyzed by reverse transcription-qPCR (RT-qPCR) (n = 2). The data represents mean. “n” indicates the number of independent experiments. (b) Top-10 significant GO terms of upregulated DEGs in 1.9–4.9krpsL HCMV infected cells at the indicated time points. The GO term ranking is determined by –log10 (adj.p-value). Adjusted p-values were based on one-sided Fisher’s exact test corrected by Benjamini-Hochberg procedure. Exact adjusted p-values are provided in Supplementray Table 3. (c) IFN-β protein levels in cell-free supernatant of HCMV-infected HFFs (1 MOI) were quantified by enzyme-linked immunosorbent assay (ELISA) at the indicated time points (n = 4). (d) Graphical abstract describing each recombinant virus. (d-e) HFFs infected with WT, 1.9–4.9krpsL, and Δ1.9–4.9k HCMV (1 MOI, 6 hpi) were analyzed by RT-qPCR (n = 3). (c-e) “n” indicates the number of independent experiments. The data are presented as mean ± SEM and P-values are based on two-sided multiple t-tests without correction. Exact P-values are provided in Source Data Extended Data Fig. 1.
Extended Data Fig. 2 RNA4.9 inhibits innate immunity in multiple HCMV-permissive cell types.
(a-c) U373MG, MRC-5, and HUVEC cells were infected with the WT and the 1.9–4.9krpsL viruses (U373MG and MRC-5; 1 MOI, HUVEC cells; 5 MOI). Viral gDNA levels were measured by qPCR at 3 hpi and RNA expressions of interferon and cytokines were measured by RT-qPCR at the indicated time points (n = 4; a, n = 3; b-c). “n” indicates the number of independent experiments. The data are presented as mean ± SEM and P-values are based on two-sided multiple t-tests without correction. Exact P-values are provided in Source Data Extended Data Fig. 2.
Extended Data Fig. 3 RNA4.9 depletion-mediated immune activation precedes inefficient viral DNA replication and viral gene expression.
(a-d) HFFs infected with WT and 1.9–4.9krpsL HCMV were harvested at the indicated time points and analyzed for viral DNA level (a), viral protein expression (b), viral mRNA level (c), and immune gene expression (d). IE1, UL44, and UL99 represent viral immediate-early, early, and late transcripts, respectively. (b) The representative images of two independent replicates are presented. See Source Data for uncropped data. (a, c-d) Data are derived from four independent experiments. The data are presented as mean ± SEM and P-values are based on two-sided multiple t-tests without correction. Exact P-values are provided in Source Data Extended Data Fig. 3.
Extended Data Fig. 4 RNA4.9 inhibits cGAS activity to facilitate HCMV lytic replication.
(a and b) HFFs were infected with WT and 1.9–4.9krpsL HCMV (1 MOI) and were fixed at 6 hpi. (a) Phosphorylated STING (S366) and TBK1 (S172) were visualized by immunofluorescence assay (IFA). (b) Phosphorylated IRF3 (S386) and IE1/2 were visualized by IFA. White dotted lines indicate the boundary of nucleus of infected cells. Mean of raw intensity of nuclear p-IRF3 (S386) was quantified by ImageJ software (Fiji) (n = 36; Mock, n = 38; WT, n = 51; 1.9–4.9krpsL). Each “n” indicates the number of cells those were used in this analysis, which is derived from three independent experiments. The dotted lines in the violin plots indicate the median values. (c-d) 2’3’-cGAMP levels in MRC-5 and HUVEC cells infected with the indicated virus (1 MOI; MRC-5, 5 MOI; HUVEC) were measured by ELISA (n = 3). “n” indicates the number of independent experiments. (b-d) The data are presented as mean ± SEM and P-values are based on two-sided multiple t-tests without correction. Exact P-values are provided in Source Data Extended Data Fig. 4. (e) Images representing viral titers at 11 dpi in Fig. 2d. The representative images of three independent experiments are presented.
Extended Data Fig. 5 RNA4.9 inhibits dsDNA-triggered immune response independently of other viral factors.
(a) Graphical abstract describing each recombinant virus. (b) HFFs infected with the indicated HCMV (1 MOI) were harvested at 3 and 6 hpi, and subjected to RT-qPCR to measure the interferon and cytokine expressions (n = 3). (c) HeLa cells were transfected with pDEST12.2-RNA4.9 and stimulated by 0.5 μg/ml of Poly (dA:dT) or Poly (I:C). After 24 h, the cells were harvested and subjected to RT-qPCR to measure the interferon RNA level (n = 3). (d) HeLa cells were transfected with pDEST12.2-RNA4.9 and stimulated by 0.5 μg/ml of Poly (dA:dT) or 5 μg/ml of 2’3’-cGAMP. After 24 h, the cells were harvested and subjected to RT-qPCR to measure the interferon and cytokine expressions (n = 3). (b-d) “n” indicates the number of independent experiments. The data are presented as mean ± SEM and P-values are based on two-sided multiple t-tests without correction. Exact P-values are provided in Source Data Extended Data Fig. 5.
Extended Data Fig. 6 RNA4.9-mediated cGAS inhibition occurs in the nucleus.
(a) RNA levels in the nuclear and cytoplasmic fractions of WT HCMV-infected HFFs (1 MOI, 6 hpi) were quantified by RT-qPCR (n = 3). NEAT1 and GAPDH served as controls for nuclear RNA and cytoplasmic RNA, respectively. (b and c) HFFs were infected with WT and 1.9–4.9krpsL HCMV (1 MOI) and subjected to nucleus/cytoplasm fractionation. (b) At 6 hpi, the level of viral DNA was analyzed by qPCR using IE1 and UL44 targeting primers (n = 3). MDM2 served as controls for host DNA. (c) At 6 hpi, the cGAS level was analyzed by immunoblotting. GAPDH and Histone H3 served as controls for cytoplasmic protein and nuclear protein, respectively. The representative images of two independent experiments are presented. See Source Data for uncropped data. (d) HFFs were infected with WT and 1.9–4.9krpsL HCMV (1 MOI). At 6 and 24 hpi, the 23´-cGAMP level in nuclear fraction was analyzed by ELISA (n = 5). (a, b, and d) “n” indicates the number of independent experiments. The data are presented as mean ± SEM and P-values are based on two-sided multiple t-tests without correction. Exact P-values are provided in Source Data Extended Data Fig. 6.
Extended Data Fig. 7 Library construction for CLIP-seq.
(a) Immunoblot images representing the IP efficiency of the endogenous cGAS in Fig. 3a (E9G9G; Cell Signaling). (b) Immunoblot images representing the IP efficiency of the cGAS variants in Fig. 3c (F3165; Sigma). (a-b) The representative images of two independent experiments are presented. (c-e) Images were obtained during CLIP-seq library construction. (c) Immunoblot images representing the IP efficiency of cGAS antibodies (D1D3G and E9G9G; Cell signaling). (d) Autoradiograph images of 32P-labeled RNA-cGAS complexes and adaptor-ligated RNAs enriched by cGAS-CLIP. PCR amplicons of CLIP-libraries were visualized by staining with EtBR. (e) Autoradiograph images of 32P-labeled fragmented RNAs from non-crosslinked cells and adaptor-ligated RNAs. PCR amplicons of SMI-libraries were visualized by staining with EtBR. (a-e) See Source Data for uncropped data. (c-e) Two independent experiments are indicated as rep #1 and #2.
Extended Data Fig. 8 The 75-nt of cGAS-binding region of RNA4.9 is critical for accelerating HCMV lytic replication.
(a) Graphical summary of ΔRNA4.9Hairpins virus generation. RNA levels in HFFs infected with the indicated HCMV (1 MOI, 6 hpi) were analyzed by RT-qPCR (n = 3). “n” indicates the number of independent experiments. The data are presented as mean ± SEM. Exact data values are provided in Source Data Extended Data Fig 8. (b) Images representing viral titers at 7 dpi in Fig. 4d. (c) Coverage of CLIP-reads and SMI-reads mapped to the 1.9–4.9-kb region of RNA4.9. Two non-cGAS-binding regions (gray box) and a predominant cGAS-binding region (red box) were selected as ASO targets. (d) Images representing viral titers at 7 dpi in Fig. 4h. (b and d) The representative images of three independent experiments are presented.
Extended Data Fig. 9 RNA4.9-cGAS interaction is uniquely involved in cGAS inhibition.
(a) Coverage of CLIP-reads and SMI-reads mapped to HCMV transcripts. Predominant cGAS-binding regions of the HCMV transcripts (red box) were selected as ASO targets. (b) HFFs were transfected with the ASOs (250 nM) and infected with WT HCMV (1 MOI). At 24 hpi, 2´3´-cGAMP levels were measured by ELISA (n = 3). N.I indicates non-infection. “n” indicates the number of independent experiments. The data are presented as mean ± SEM and P-values are based on two-sided multiple t-tests without correction. Exact P-values are provided in Source Data Extended Data Fig 9.
Extended Data Fig. 10 Characterization of RNA4.9 localization of the mutant viruses.
(a) Linescan profile from the normalized intensity of HCMV DNA and IE1/2 foci signals (related to Fig. 5a; n = 11). Signal distributions of HCMV DNAs are identical with those in Fig. 5b. “n” indicates the number of nuclear HCMV DNA or IE1/2 signals which were observed in the cells from three independent experiments. The cell numbers are identical with Extended Data Fig. 10b. The bold line and the shaded region indicate mean and 95% confidence interval (CI), respectively (b) The ratio of IE1/2 or RNA4.9 signals associated with EdU signals to total EdU signals in the nucleus was quantified (related to Fig. 5a). For each channel, the signals with an intensity in the upper 0.05 to 0.1% in the nucleus participated in quantification to exclude background noise signal. Each dot represents the individual cell (n = 6). “n” indicates the number of cells those were used in this analysis, which was obtained from three independent experiments. (c and f) Graphical abstract describing each recombinant virus. RNA levels in HFFs infected with the indicated HCMV (1 MOI, 6 hpi) were analyzed by RT-qPCR (n = 3). (d and g) Viral gDNA levels in HFFs infected with the indicated HCMV (1 MOI, 3 hpi) were analyzed by qPCR (n = 3). (e) Viral productions from the HFFs infected with the indicated HCMV (0.1 MOI) were titrated by limiting dilution analysis (n = 3). (c-g) “n” indicates the number of independent experiments. (b-g) The data are presented as mean ± SEM and P-values are based on two-sided multiple t-tests without correction. Exact P-values are provided in Source Data Extended Data Fig 10.
Supplementary information
Supplementary Information (download PDF )
Supplementary Figs. 1–8 and Source Data for Supplementary Fig. 7.
Supplementary Data (download XLSX )
Statistical source data for Supplementary Figs. 1–3 and 5–6.
Supplementary Table 1 (download XLSX )
Primers for BAC mutagenesis.
Supplementary Table 2 (download XLSX )
Primers for qPCR.
Supplementary Table 3 (download XLSX )
mRNA sequencing data.
Supplementary Table 4 (download XLSX )
Modified ASOs.
Supplementary Table 5 (download XLSX )
smFISH probes.
Supplementary Table 6 (download XLSX )
PCR primers for construction of CLIP and SMI libraries.
Supplementary Table 7 (download XLSX )
TPM for the HCMV transcripts from CLIP-seq.
Source data
Source Data Fig. 1 (download XLSX )
Statistical source data for Fig. 1.
Source Data Fig. 2 (download XLSX )
Statistical source data for Fig. 2.
Source Data Fig. 3 (download XLSX )
Statistical source data for Fig. 3.
Source Data Fig. 4 (download XLSX )
Statistical source data for Fig. 4.
Source Data Fig. 5 (download XLSX )
Statistical source data for Fig. 5.
Source Data Fig. 6 (download XLSX )
Statistical source data for Fig. 6.
Source Data Extended Data Fig. 1 (download XLSX )
Statistical source data for Extended Data Fig. 1.
Source Data Extended Data Fig. 2 (download XLSX )
Statistical source data for Extended Data Fig. 2.
Source Data Extended Data Fig. 3 (download XLSX )
Statistical source data for Extended Data Fig. 3.
Source Data Extended Data Fig. 4 (download XLSX )
Statistical source data for Extended Data Fig. 4.
Source Data Extended Data Fig. 5 (download XLSX )
Statistical source data for Extended Data Fig. 5.
Source Data Extended Data Fig. 6 (download XLSX )
Statistical source data for Extended Data Fig. 6.
Source Data Extended Data Fig. 8 (download XLSX )
Statistical source data for Extended Data Fig. 8.
Source Data Extended Data Fig. 9 (download XLSX )
Statistical source data for Extended Data Fig. 9.
Source Data Extended Data Fig. 10 (download XLSX )
Statistical source data for Extended Data Fig. 10.
Source Data Figs. 1 and 2, and Extended Data Figs. 3, 6 and 7 (download PDF )
Uncropped immune blots and gels of Figs. 1 and 2, and Extended Data Figs. 3, 6 and 7.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lee, S., Kim, S., Kim, H. et al. Human cytomegalovirus long non-coding RNA counteracts nuclear cGAS to facilitate immune evasion. Nat Microbiol 10, 2275–2290 (2025). https://doi.org/10.1038/s41564-025-02078-5
Received:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41564-025-02078-5
This article is cited by
-
HIV infection reprogrammes CD4+ T cells for quiescence and entry into proviral latency
Nature Microbiology (2025)


